nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—Glomerulonephritis—Propylthiouracil—Graves' disease	0.109	0.125	CcSEcCtD
Pregabalin—Splenomegaly—Propylthiouracil—Graves' disease	0.0717	0.0823	CcSEcCtD
Pregabalin—Nephritis—Methimazole—Graves' disease	0.0685	0.0786	CcSEcCtD
Pregabalin—Nephritis—Propylthiouracil—Graves' disease	0.0582	0.0668	CcSEcCtD
Pregabalin—Neuritis—Methimazole—Graves' disease	0.0313	0.036	CcSEcCtD
Pregabalin—Ageusia—Methimazole—Graves' disease	0.0289	0.0331	CcSEcCtD
Pregabalin—Neuritis—Propylthiouracil—Graves' disease	0.0266	0.0306	CcSEcCtD
Pregabalin—Skin ulcer—Propylthiouracil—Graves' disease	0.0256	0.0293	CcSEcCtD
Pregabalin—SLC1A1—pituitary gland—Graves' disease	0.0249	0.194	CbGeAlD
Pregabalin—SLC1A1—adipose tissue—Graves' disease	0.0248	0.193	CbGeAlD
Pregabalin—Ageusia—Propylthiouracil—Graves' disease	0.0246	0.0282	CcSEcCtD
Pregabalin—SLC1A1—thyroid gland—Graves' disease	0.0215	0.167	CbGeAlD
Pregabalin—Vasculitis—Propylthiouracil—Graves' disease	0.0204	0.0234	CcSEcCtD
Pregabalin—Lymphadenopathy—Methimazole—Graves' disease	0.0199	0.0228	CcSEcCtD
Pregabalin—CACNA2D2—pituitary gland—Graves' disease	0.018	0.14	CbGeAlD
Pregabalin—Lymphadenopathy—Propylthiouracil—Graves' disease	0.0169	0.0194	CcSEcCtD
Pregabalin—Renal failure acute—Propylthiouracil—Graves' disease	0.0156	0.018	CcSEcCtD
Pregabalin—CACNA2D2—thyroid gland—Graves' disease	0.0155	0.12	CbGeAlD
Pregabalin—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.0153	0.0176	CcSEcCtD
Pregabalin—CACNA2D1—adipose tissue—Graves' disease	0.0129	0.1	CbGeAlD
Pregabalin—Neuropathy peripheral—Methimazole—Graves' disease	0.0128	0.0147	CcSEcCtD
Pregabalin—Jaundice—Methimazole—Graves' disease	0.0128	0.0146	CcSEcCtD
Pregabalin—Hepatitis—Methimazole—Graves' disease	0.0117	0.0135	CcSEcCtD
Pregabalin—CACNA2D1—thyroid gland—Graves' disease	0.0112	0.0866	CbGeAlD
Pregabalin—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.0109	0.0125	CcSEcCtD
Pregabalin—Jaundice—Propylthiouracil—Graves' disease	0.0108	0.0125	CcSEcCtD
Pregabalin—Alopecia—Methimazole—Graves' disease	0.0104	0.0119	CcSEcCtD
Pregabalin—Haemoglobin—Propylthiouracil—Graves' disease	0.01	0.0115	CcSEcCtD
Pregabalin—Haemorrhage—Propylthiouracil—Graves' disease	0.00999	0.0115	CcSEcCtD
Pregabalin—Hepatitis—Propylthiouracil—Graves' disease	0.00999	0.0115	CcSEcCtD
Pregabalin—Vertigo—Methimazole—Graves' disease	0.00919	0.0105	CcSEcCtD
Pregabalin—Leukopenia—Methimazole—Graves' disease	0.00915	0.0105	CcSEcCtD
Pregabalin—Alopecia—Propylthiouracil—Graves' disease	0.00883	0.0101	CcSEcCtD
Pregabalin—Myalgia—Methimazole—Graves' disease	0.00871	0.00999	CcSEcCtD
Pregabalin—Arthralgia—Methimazole—Graves' disease	0.00871	0.00999	CcSEcCtD
Pregabalin—Dysgeusia—Propylthiouracil—Graves' disease	0.00852	0.00977	CcSEcCtD
Pregabalin—Oedema—Methimazole—Graves' disease	0.00835	0.00958	CcSEcCtD
Pregabalin—Thrombocytopenia—Methimazole—Graves' disease	0.00817	0.00938	CcSEcCtD
Pregabalin—Vertigo—Propylthiouracil—Graves' disease	0.00781	0.00897	CcSEcCtD
Pregabalin—Leukopenia—Propylthiouracil—Graves' disease	0.00778	0.00894	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Methimazole—Graves' disease	0.0076	0.00873	CcSEcCtD
Pregabalin—Paraesthesia—Methimazole—Graves' disease	0.00749	0.0086	CcSEcCtD
Pregabalin—Somnolence—Methimazole—Graves' disease	0.00742	0.00852	CcSEcCtD
Pregabalin—Arthralgia—Propylthiouracil—Graves' disease	0.0074	0.0085	CcSEcCtD
Pregabalin—Myalgia—Propylthiouracil—Graves' disease	0.0074	0.0085	CcSEcCtD
Pregabalin—Oedema—Propylthiouracil—Graves' disease	0.0071	0.00815	CcSEcCtD
Pregabalin—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00695	0.00798	CcSEcCtD
Pregabalin—Urticaria—Methimazole—Graves' disease	0.00663	0.00761	CcSEcCtD
Pregabalin—Body temperature increased—Methimazole—Graves' disease	0.0066	0.00757	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00647	0.00742	CcSEcCtD
Pregabalin—Paraesthesia—Propylthiouracil—Graves' disease	0.00637	0.00732	CcSEcCtD
Pregabalin—Somnolence—Propylthiouracil—Graves' disease	0.00631	0.00724	CcSEcCtD
Pregabalin—Pruritus—Methimazole—Graves' disease	0.00591	0.00678	CcSEcCtD
Pregabalin—Urticaria—Propylthiouracil—Graves' disease	0.00564	0.00647	CcSEcCtD
Pregabalin—Body temperature increased—Propylthiouracil—Graves' disease	0.00561	0.00644	CcSEcCtD
Pregabalin—Vomiting—Methimazole—Graves' disease	0.00531	0.00609	CcSEcCtD
Pregabalin—Rash—Methimazole—Graves' disease	0.00526	0.00604	CcSEcCtD
Pregabalin—Dermatitis—Methimazole—Graves' disease	0.00526	0.00604	CcSEcCtD
Pregabalin—Headache—Methimazole—Graves' disease	0.00523	0.006	CcSEcCtD
Pregabalin—Pruritus—Propylthiouracil—Graves' disease	0.00502	0.00576	CcSEcCtD
Pregabalin—Nausea—Methimazole—Graves' disease	0.00496	0.00569	CcSEcCtD
Pregabalin—Vomiting—Propylthiouracil—Graves' disease	0.00451	0.00518	CcSEcCtD
Pregabalin—Rash—Propylthiouracil—Graves' disease	0.00447	0.00514	CcSEcCtD
Pregabalin—Dermatitis—Propylthiouracil—Graves' disease	0.00447	0.00513	CcSEcCtD
Pregabalin—Headache—Propylthiouracil—Graves' disease	0.00445	0.0051	CcSEcCtD
Pregabalin—Nausea—Propylthiouracil—Graves' disease	0.00422	0.00484	CcSEcCtD
